:


Bertina RM et al: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64, 1994

Bounameaux H et al: Plasma measurement of D-dimer as diagnostic aid in suspected venous thromboembolism: An overview. Thromb Haemost 71:1, 1994

Goldhaber SZ (ed.): Prevention of Venous Thromboembolism. New York, Marcel Dekker, 1993

Goldhaber SZ et al: Alteplase versus heparin in acute pulmonary embolism: Randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet 341:507, 1993

Goldhaber SZ (ed.): Cardiopulmonary diseases and cardiac tumors, vol 3, in Atlas of Heart Diseases, E Braunwald (Series ed). Philadelphia, Current Medicine, 1995

Goldhaber SZ: Contemporary pulmonary embolism thrombolysis. Chest 107:458, 1995

Hirsch DR et al: A prospective study of deep venous thrombosis in medical intensive care unit patient. JAMA 274:335, 1995

Lualdi JC, Goldhaber SZ: Right ventricular dysfunction after acute pulmonary embolism: Pathophysiologic factors, detection, and therapeutic implications. Am Heart J 130:1276, 1995

Raschke RA et al: The weight-based heparin dosing nomogram compared with a 'standard care' nomogram: A randomized controlled trial. Ann Intern Med 119:874, 1993

Ridker PM et al: Mutation in the gene coding for coagulation factor Vand risks of future myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 332:912, 1995

Schulman S et al: A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med 332:1661, 1995

Stein PD et al: Complications and validity of pulmonary angiography in acute pulmonary embolism. Circulation 85:462, 1992

Stein PD et al: Arterial blood gas analysis in the assessment of suspected acute pulmonary embolism. Chest 109:78, 1996

:

  • ()